Estimation of serum homocysteine & lipid profile in chronic kidney disease patients
Keywords:
Chronic Kidney Disease, Homocysteine, Lipid ProfileAbstract
Background: Chronic kidney disease (CKD) is a deterioration of renal function, which results from diminished effective functioning of renal tissue. CKD is associated with dyslipidemia associating hypertriglyceridemia, elevated LDL cholesterol, an accumulation of apolipoprotein B (Apo B) containing lipoproteins, increased concentrations of lipoprotein(a) particles, and low HDL levels. Homocystein is considered as a risk or pathogenic factor in the progression of CKD which has been considered globally as a serious health issue. Aim & Objective: To estimate and compare the levels of serum homocysteine & lipid profile between chronic kidney disease patients and healthy individuals. Materials & Methods: The present case control study was conducted at Dhiraj General hospital, Piparia, Vadodara, Gujarat, India in which 100 age and sex matched subjects were enrolled, out of which 50 were cases of CKD patients and 50 were controls. Approximately 5 ml of fasting blood sample was drawn from the each person with aseptic precautions. Serum was separated which was used for the estimation of serum homocysteine, lipid profile, serum creatinine and blood urea.
Downloads
References
Kesarwani A, Asegaonkar SB, Jha A. Study of Serum homocysteine and lipid profile parameters in patients of chronic renal failure. Int J Health Sci Res. 2017; 7(8):142-49.
Markus Kettelar, Geoffrey A Block, et al. Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder: Synopsis of the Kidney Disease: Improving Global Outcomes 2017 Clinical Practice Guideline Update. Clinical Guidelines, March 2018. https://doi.org/10.7326/M17-2640.
Nelva T de Gómez, Ana M Giammona, et al. Variations in the lipid profile of patients with chronic renal failure treated with pyridoxine. Lipids in the health and disease.2003; 2(7):1-6.
Mustafa C. Bulbul, Tuncay Dagel, et al. Disorders of Lipid Metabolism in Chronic Kidney Disease. Blood Purif. 2018;46:144–52.
Hatem K. Amin, Mohamed-I Kotb El-Sayed & Ola F. Leheta. Homocysteine as a predictive biomarker in early diagnosis of renal failure susceptibility and prognostic diagnosis for end stages renal disease. Renal Failure.2016;38(8),1267-75, DOI:10.1080/0886022X.2016.1209382
Azmi MA, et al. Determination of Homocysteine and Lipid Profile Level in the Blood of Chronic Kidney Disease Patients with and without Hemodialysis in Comparison to Normal Healthy Individuals. J Urol Nephrol. 2018, 3(4): 000150.
Allon n. Friedman, Andrew g. Bostom, et al. The Kidney and Homocysteine Metabolism. J Am Soc Nephrol. 2001; 12: 2181–9.
Roberto Trevisan, Alessandro R. Dodesini, et al. Lipids and Renal Disease. JASN. April 2006, 17 (4 suppl 2) S145-S147.
Coen van Guldener. Why is homocysteine elevated in renal failure and what can be expected from homocysteine-lowering? Nephrology Dialysis Transplantation. 2006; 21(5):1161–66.
Cianciolo G.,De Pascalis A, et al. Folic Acid and Homocysteine in Chronic Kidney Disease and Cardiovascular Disease Progression: Which Comes First. Cardiorenal Med. 2017;7:255-66.
Ajay Kumar Katiyar1, S. K. Katiyar. Study of lipid profile and homocysteine levels in cases of chronic kidney disease. Journal of Evolution of Medical and Dental Sciences. 2014; 3(26):7135-42.
Diniari, N. K. S., & Aryani, L. N. A. (2022). Characteristics and pharmacological treatment options of delirium patients treated at Sanglah Central General Hospital. International Journal of Health & Medical Sciences, 5(1), 37-43. https://doi.org/10.21744/ijhms.v5n1.1835
Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2022). Post-pandemic health and its sustainability: Educational situation. International Journal of Health Sciences, 6(1), i-v. https://doi.org/10.53730/ijhs.v6n1.5949
Adejumo OA, Okaka EI, Ojogwu LI. Lipid profile in pre-dialysis chronic kidney disease patients in southern Nigeria. Ghana Med J. 2016;50(1):44-9. doi:10.4314/gmj.v50i1.7
Dr Sarita H Patel, Dr Milav Bhavsar, et al. Study of Lipid profile in chronic kidney disease patients. Journal of Medical Science and Clinical Research. April 2019; 07(04): DOI: https://dx.doi.org/10.18535/jmscr/v7i4.113
Vandana Yadav, Vivek Prakash, et al. Study of serum homocysteine level in patients with chronic kidney disease and its association with renal function and serum albumin. Int J Res Med Sci. June 2020; 08(06):2195-8.
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
![Creative Commons License](http://i.creativecommons.org/l/by-nc-nd/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.